Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Ovary (Late Stage^), 2018-2022

All Races (includes Hispanic), Female, All Ages

Sorted by Percentlate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Idaho7


Connecticut7


Utah7


Georgia7


Massachusetts2


Iowa7


Washington1


California7


New York7


Michigan2


Alaska2


Louisiana7


Delaware2


Oregon2


Indiana2


New Jersey7


North Dakota2


Kansas2


North Carolina2


Illinois7


Nebraska2


New Hampshire2


Kentucky7


Pennsylvania2


Missouri2


Wisconsin2


Maryland2


South Dakota2


Colorado2


South Carolina2


Vermont2


Mississippi2


Arizona2


Oklahoma2


Wyoming2


Florida2


Ohio2


New Mexico7


Tennessee2


Virginia2


Arkansas2


Montana2


Texas7


West Virginia2


Puerto Rico2


Hawaii7


Rhode Island2


Alabama2


Maine2


Minnesota2


Nevada2


District of Columbia2





Notes:
Created by statecancerprofiles.cancer.gov on 03/29/2026 1:23 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.